About this trial
Ganyan -1 for the patients with dry eye
Eligibility criteria
Qualifiers
None
Disqualifiers
History systemic autoimmune diseases and ocular/periocular malignancy.
Clinically relevant slitlamp findings or abnormal lid anatomy.
Active ocular allergies and active infection.
Pregnant or lactating women.
Trial design
Treatments tested in this trial
- Ganyan1
- Sodium Hyaluronate
- 1/2Ganyan1
- Placebo
Treatment groups
219 Participants
are divided into 3 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov